Novelix Pharmaceuticals Approves Redesignation of Venkateshwarlu Pulluru as Non-Executive Director
Novelix Pharmaceuticals Ltd 路 Change in Management 路 12 Nov 2026, 10:35 pm
Novelix Pharmaceuticals Approves Redesignation of Venkateshwarlu Pulluru as Non-Executive Director Novelix Pharmaceuticals Limited announced that its Board of Directors approved the redesignation of Mr. Venkateshwarlu Pulluru from Whole-Time Director to Non-Executive Non-Independent Director, effective from the close of business hours on 11th Nov'26. Following his request to relinquish executive responsibilities due to personal and professional commitments, Mr. Pulluru will continue to serve on the board as a director liable to retire by rotation, ensuring continuity of his directorship.
Original exchange filing (PDF)
More announcements from Novelix Pharmaceuticals Ltd
- Submission of Intimation of Corporate office opening. 路 18 Nov 2026
- Submission of Supply agreement intimation. 路 13 Nov 2026
- Attached as per above Subject. 路 12 Nov 2026
- Submission of unaudited financial results for the quarter and half year ended September, 2026. 路 12 Nov 2026
- Submission of outcome of the Board Meeting. 路 12 Nov 2026
- Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve unaudited standalone .... 路 11 Nov 2026
- Attached 路 03 Oct 2026
- Attached 路 02 Oct 2026
